Project Details
Description
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the prevention of Excessive Bleeding in Patients with Congenital Hemophilia A or B with Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedure
| Status | Active |
|---|---|
| Effective start/end date | 5/10/23 → 5/31/28 |
Funding
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.